The Food and Drug Administration authorized four of Altria’s menthol e-cigarettes for sale in the country on Friday, making them the first ever flavored vapes the agency has permitted on the market.

A report that the Food and Drug Administration might order Juul to pull its products from store shelves has sent shares of Altria plunging. The cigarette company owns a 35% stake in Juul.

The U.S. Food and Drug Administration authorized four of Altria's menthol e-cigarette products for sale in the country on Friday, making them the first ever flavored vapes the agency has permitted ...

WASHINGTON — The Food and Drug Administration is accusing Juul and Altria of reneging on promises they made to the government to keep e-cigarettes away from minors. Dr. Scott Gottlieb, the ...

Global tobacco giant Altria is following up a big investment in a ... Parman noted that the company did not submit the devices to the U.S. Food and Drug Administration for approval before a ...

RICHMOND — Henrico County-based Altria Group Inc. must stop selling the alternative smoking device ... The U.S. Food and Drug Administration had given Altria permission to market the product as ...

Marlboro maker Altria Group Inc. is calling on the US Food and Drug Administration to do more to crack down on the illegal vape products that compete with its own authorized product, NJOY.

Altria Group MO-0.07 % decrease; red down pointing triangle has submitted a premarket tobacco product application for its on! Plus oral nicotine pouches to the Food and Drug Administration.

Altria Group said it would pull its e-cigarette pods from the market and discontinue the sale of most ... The Food and Drug Administration has warned of a public-health crisis from ...

In 2019, the Food and Drug Administration said a different oral tobacco product, called snus, contains lower cancer-causing chemicals than cigarettes and could benefit smokers who switch.

It broke from the Big Tobacco pack and began supporting legislation that would ultimately put the company under the regulatory thumb of the Food and Drug Administration. Altria’s motives for ...

Altria Group Inc. MO said Thursday it expects 2023 adjusted profit of $4.89 to $5.03 a share, compared to the FactSet analyst projection of $5.05 a share. Altria said it has closed its NJoy ...